SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...
Stocktwits on MSN5d
SpringWorks Therapeutics Leads Biotech Pack In Weekly Retail Follower Surge: What's Fueling Interest?SpringWorks Therapeutics (SWTX) saw the biggest retail follower increase among biotech stocks last week on Stocktwits, even ...
The FDA has approved SpringWorks Therapeutics’s mirdametinib (Gomekli ... drug for the treatment of paediatric low-grade gliomas. Merck KGaA is reportedly in discussions to acquire SpringWorks ...
Hard on the heels of the disclosure that Merck KGaA is talking to SpringWorks about a possible takeover, a new FDA approval could have sweetened the deal. Stamford, Connecticut-based SpringWorks ...
SpringWorks Therapeutics was my first experience in fundraising for an early-stage company. My previous experiences were in management roles at revenue-generating global commercial-stage biotech ...
Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...
After hours: March 11 at 7:56:41 PM EDT Loading Chart for SWTX ...
Shares of Trevi Therapeutics TRVI surged 41% yesterday ... Another company that was once ahead in the RCC drug race was Merck MRK, whose chronic cough drug, gefapixant, received two complete ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback